Page last updated: 2024-10-28

guanethidine and Polycystic Ovary Syndrome

guanethidine has been researched along with Polycystic Ovary Syndrome in 1 studies

Guanethidine: An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues.
guanethidine : A member of the class of guanidines in which one of the hydrogens of the amino group has been replaced by a 2-azocan-1-ylethyl group.
guanethidine sulfate : A organic sulfate salt composed of two molecules of guanethidine and one of sulfuric acid.

Polycystic Ovary Syndrome: A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Espinoza, JA1
Alvarado, W1
Venegas, B1
Domínguez, R1
Morales-Ledesma, L1

Other Studies

1 other study available for guanethidine and Polycystic Ovary Syndrome

ArticleYear
Pharmacological sympathetic denervation prevents the development of polycystic ovarian syndrome in rats injected with estradiol valerate.
    Reproductive biology and endocrinology : RB&E, 2018, Sep-07, Volume: 16, Issue:1

    Topics: Adrenergic Neurons; Animals; Estradiol; Female; Guanethidine; Ovary; Polycystic Ovary Syndrome; Rand

2018